Professor of Surgery, University Tex Houston
General Surgery
Dr. Merrick I. Ross, MD
|
|
Give Review
Merrick Ross practices General Surgery. He went to University of Illinois College of Medicine at Chicago. University of Illinois College of Medicine at Chicago has a rank of 49 in research and a 85 in primary care He over the years received 6 awards: "America's Top Doctors", "Top Doctors:SE Texas", "America's Top Doctors for Cancer", "Redbook Magazine: Top Breast Cancer Doctors", "Fellow (FACS)" and "Super Doctor". Merrick Ross is a published doctor. He published 101 publications, including: 'Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b ...' He is registered with Medicare.
Publications
- Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b ...
- Excision Margins of Melanoma Make a Difference: New Data Support an Old Paradigm.
- Is surviving enough? Coping and impact on activities of daily living among melanoma patients with lymphoedema.
- A multicenter phase I dose escalation trial to evaluate safety and tolerability of intra-Arterial temozolomide for patients with advanced extremity melanoma using norm...
- Clinical study of noninvasive in vivo melanoma and nonmelanoma skin Cancers using multimodal spectral diagnosis.
- The relationship between blood IL-12p40 level and melanoma progression.
- Melanoma, version 4.2014.
- Intralesional therapy with PV-10 (Rose Bengal) for in-transit melanoma.
- Age as a Predictor of Sentinel Node Metastasis among Patients with Localized Melanoma: An Inverse Correlation of Melanoma Mortality and Incidence of Sentinel Node Meta...
- The role of adjuvant radiotherapy in the local management of desmoplastic melanoma.
- Is Surveillance Imaging Effective for Detecting Surgically Treatable Recurrences in Patients With Melanoma? A Comparative Analysis of Stage-Specific Surveillance Strat...
- Prospective assessment of lymphedema incidence and lymphedema-associated symptoms following lymph node surgery for melanoma.
- Age as a prognostic factor in patients with localized melanoma and regional metastases.
- Melanoma, Version 2.2013: Featured Updates to the NCCN Guidelines.
- Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma.
- Diversity of stage III melanoma in the era of sentinel lymph node biopsy.
- Impact of chemotherapy sequencing on local-regional failure risk in breast Cancer patients undergoing breast-conserving therapy.
- Specific Lymphocyte Subsets Predict Response to Adoptive Cell Therapy Using Expanded Autologous Tumor-Infiltrating Lymphocytes in Metastatic Melanoma Patients.
- Histologic features of conjunctival melanoma predictive of metastasis and death (an american ophthalmological thesis).
- Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast Cancer patients with a positive sentinel l...
- Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker.
- Prospective Evaluation of the Nipple-Areola Complex Sparing Mastectomy for Risk Reduction and for Early-Stage Breast Cancer.
- Evidence-based treatment of early-stage melanoma.
- Mapping FACT-Melanoma Quality-of-Life Scores to EQ-5D Health Utility Weights.
- Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
- Randomized Multicenter Trial of the Effects of Melanoma-Associated Helper Peptides and Cyclophosphamide on the Immunogenicity of a Multipeptide Melanoma Vaccine.
- Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapy.
- Sentinel-lymph-node biopsy for cutaneous melanoma.
- Prognostic Significance of Mitotic Rate in Localized Primary Cutaneous Melanoma: An Analysis of Patients in the Multi-Institutional American Joint Committee on Cancer ...
- Sphincter-sparing local excision and hypofractionated radiation therapy for anoRectal melanoma: A 20-Year Experience.
- Prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanoma.
- Local, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomy.
- Classification of ipsilateral Breast tumor recurrences after Breast conservation therapy can predict patient prognosis and facilitate treatment planning.
- Multidisciplinary Considerations in the Implementation of the Findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 Study: A Practice-Changing T...
- Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-Analysis.
- Isolated limb perfusion for unresectable extremity sarcoma: Results of 2 single-institution phase 2 trials.
- Metastasectomy for stage IV melanoma: for whom and how much?
- Sentinel lymph node biopsy for melanoma: critical assessment at its twentieth anniversary.
- The prognostic significance of nonsentinel lymph node metastasis in melanoma.
- Sentinel node biopsy for melanoma: an update after two decades of experience.
- Sentinel lymph node dissection is technically feasible in older breast Cancer patients.
- Lymphedema beyond breast Cancer: a systematic review and meta-analysis of Cancer-related secondary lymphedema.
- Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: Analysis of 5823 cases as the basis of the first consensus staging system.
- Prospective assessment of postoperative complications and associated costs following Inguinal lymph node dissection (ILND) in melanoma patients.
- Surveillance after surgical treatment of melanoma: futility of routine chest radiography.
- Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma.
- Conditional survival estimates improve over 5 years for melanoma survivors with node-positive Disease.
- Prognostic information from sentinel lymph node biopsy in patients with thick melanoma.
- Second primary melanomas: incidence and outcome.
- Histologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive breast Cancer bef...
- Multivariate Analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases.
- Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based Analysis.
- Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
- Factors associated with false-negative sentinel lymph node biopsy in melanoma patients.
- Final version of 2009 AJCC melanoma staging and classification.
- Effect of granulocyte/macrophage colony-stimulating factor on circulating CD8+ and CD4+ T-cell responses to a multipeptide melanoma vaccine: outcome of a multicenter r...
- Sentinel lymph node biopsy for ocular adnexal melanoma: experience in 30 patients.
- A phase 1 study of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with locally advanced in-transit malignant melanoma.
- Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast Cancer patients.
- Predictive factors of regional toxicity and serum creatine phosphokinase levels after isolated limb infusion for melanoma: a multi-institutional Analysis.
- Do melanoma patients from Southern climates have a worse outcome than those from Northern climates?
- Lymph node ratio predicts Disease-specific survival in melanoma patients.
- A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US.
- Sentinel node biopsy and standard of care for melanoma.
- Radiation therapy field extent for adjuvant treatment of axillary metastases from malignant melanoma.
- A prospective study comparing touch imprint cytology, frozen section Analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lym...
- Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast Cancer pa...
- Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma.
- Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast Cancer.
- How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast Cancer?
- Factors predicting additional Disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy.
- Timing of surgical intervention for the intact primary in stage IV breast Cancer patients.
- Prospective assessment of the reliability, validity, and sensitivity to change of the Functional Assessment of Cancer Therapy-Melanoma questionnaire.
- Adjuvant high-dose interferon for cutaneous melanoma is most beneficial for patients with early stage III Disease.
- How should we view the results of the Multicenter Selective Lymphadenectomy Trial-1 (MSLT-1)?
- Melanoma Adrenal metastasis: natural history and surgical management.
- Decision Analysis to assess the efficacy of routine sentinel lymphadenectomy in patients undergoing prophylactic mastectomy.
- Factors associated with improved survival among young adult melanoma patients despite a greater incidence of sentinel lymph node metastasis.
- Pneumoperitoneum in the Cancer patient.
- Pelvic lymph node Dissection is beneficial in subsets of patients with node-positive melanoma.
- Metastases to the Breast from nonBreast solid neoplasms: presentation and determinants of survival.
- Sentinel lymph node biopsy for sebaceous cell Carcinoma and melanoma of the ocular adnexa.
- Cost effectiveness of adjuvant interferon in node-positive melanoma.
- Role for intraoperative margin assessment in patients undergoing Breast-conserving surgery.
- Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast Cancer patients with documented axillary metastases.
- Genetic variants of the vitamin D receptor gene alter risk of cutaneous melanoma.
- Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
- Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control Analysis.
- Is intraoperative touch imprint cytology of sentinel lymph nodes in patients with breast Cancer cost effective?
- Selective use of sentinel lymph node surgery during prophylactic mastectomy.
- Impact of sentinel lymph node biopsy on the evolution of Breast reconstruction.
- Comparative analysis of sentinel lymph node operation in male and female breast Cancer patients.
- Ethnic differences among patients with cutaneous melanoma.
- Sentinel lymph node surgery in locally recurrent breast Cancer.
- Invasive squamous cell Carcinoma of the skin: defining a high-risk group.
- Acne vulgaris: false-positive finding on integrated 18F-FDG PET/CT in a patient with melanoma.
- Use of lymphoscintigraphy defines lymphatic drainage patterns before sentinel lymph node biopsy for breast Cancer.
- Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma.
- Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma.
- Effect of primary tumor extirpation in breast Cancer patients who present with stage IV disease and an intact primary tumor.
Schools
University of Illinois At Chicago College of Medicine
Scripps Clinic
University Il College Of Med
Procedures Preformed
- Biopsy of Breast
- Breast Reconstruction
- Destruction of Anal Tumor
- Dressing and-or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy)
- View All
Conditions Treated
- Abdominal Pain
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anal Fissure
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:SE Texas
- America's Top Doctors for Cancer
- Redbook Magazine: Top Breast Cancer Doctors
- Fellow (FACS)
- Super Doctor
Education
-
University of Texas MD Anderson Cancer Center -
University of Illinois College of Medicine at Chicago -
Scripps Clinic -
University of Illinois College of Medicine
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1528154549 | |
| NPPES Provider LastName | ROSS | |
| NPPES Provider FirstName | MERRICK | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Surgical Oncology | |
| Total Claim Count | 114.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 39.0 | |
| Percent Opioid Claims | 34.21 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1528154549 |
| Last Name Of The Provider | ROSS |
| First Name Of The Provider | MERRICK |
| View All |
Similar Doctors
|
Dr. Phillip G. Sutton, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott D. Oates, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven M. Hammerman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Darlene M. Miltenburg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Miguel A. Rodriguez-Bigas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christina E. Bailey, MD |
|
|
Dr. Zerremi D. Caga-Anan, MD |